Dysautonomia is an umbrella term for conditions in which the autonomic nervous system, the part that runs heart rate, blood pressure, digestion, and temperature without your conscious input, does not regulate the body reliably. Researchers are actively studying links between this dysregulation and chronic immune activation, but inflammation is one thread in a complex picture, not a proven single cause or a diagnosis.
Key takeaways
- Dysautonomia describes a group of disorders of the autonomic nervous system, including POTS, neurocardiogenic syncope, and autonomic neuropathies, not one disease.
- Diagnosis is clinical, based on symptoms and tests like an active stand or tilt-table, not on any single blood marker.
- Research has reported associations between autonomic dysfunction and chronic inflammation, often after infection, but association is not proof of cause.
- Cytokines such as IL-6, TNF, and interferon-driven chemokines are studied as context for immune activity, not as a test for dysautonomia.
- Inflammation profiling is a research and monitoring tool to discuss with your own doctor, not a diagnosis and not a substitute for care.
What is dysautonomia, in plain language?
Your autonomic nervous system is the automatic control layer of the body. It has two main branches: the sympathetic system, which speeds things up under stress, and the parasympathetic system, which slows them back down. When these branches fall out of balance, the result is dysautonomia. It is not a single diagnosis but a family of conditions. Postural orthostatic tachycardia syndrome (POTS) is the most talked-about form, where standing up triggers a large jump in heart rate. Others include neurocardiogenic (vasovagal) syncope, orthostatic hypotension, and autonomic neuropathies tied to other diseases.
The symptoms are wide-ranging and often invisible on standard tests: lightheadedness, racing heart, fatigue, brain fog, temperature swings, digestive trouble, and exercise intolerance. Because these overlap with so many other conditions, people are frequently told their workup is normal and sent home. The patient advocacy organization Dysautonomia International notes that these disorders are common yet widely underrecognized, which is part of why so many people wait years for an explanation.
What are the researched causes of dysautonomia?
When people search for dysautonomia causes, they usually want a single answer. The honest picture is that there are many, and in a large share of cases no clear trigger is ever pinned down. Recognized contributors and associations described in the medical literature include:
- Post-infectious onset: symptoms beginning after a viral illness, including after COVID-19, is a pattern reported by clinicians and researchers.
- Autoimmune and immune-mediated processes: some forms are linked to autoantibodies or occur alongside autoimmune conditions.
- Connective tissue differences: hypermobility spectrum disorders and Ehlers-Danlos syndrome are frequently seen alongside POTS.
- Other diseases: diabetes, amyloidosis, and certain neurological conditions can damage autonomic nerves.
- Deconditioning and low blood volume: physical factors that can amplify orthostatic symptoms.
The post-infectious pattern is what has drawn attention to the immune system. If a condition often starts after an infection, it is reasonable for researchers to ask whether lingering immune activity plays a role. That question is open, not settled.
How is dysautonomia linked to chronic inflammation?
There is a plausible, well-studied two-way relationship between the autonomic nervous system and the immune system. The vagus nerve, a major parasympathetic pathway, participates in what scientists call the inflammatory reflex, a circuit that can dampen inflammatory signaling. When autonomic regulation is disturbed, that braking function may work less effectively, and ongoing inflammation can in turn affect nerve signaling. This is why dysautonomia inflammation research looks at both directions at once.
Studies of post-viral illness have reported that some patients show elevated or altered levels of circulating immune proteins. Cytokines like IL-6 and TNF, and interferon-driven chemokines such as CXCL10 (IP-10), are among the signals examined as markers of immune activity. It is important to read this carefully: finding differences in group averages across a study population is not the same as having a blood test that identifies dysautonomia in an individual. No such validated diagnostic marker exists today. Inflammation profiling adds context about what the immune system is doing; it does not diagnose an autonomic disorder.
Can a blood test diagnose dysautonomia?
No. Diagnosis of dysautonomia is clinical. It rests on a careful history and objective autonomic testing, most commonly an active stand test or a tilt-table test, where heart rate and blood pressure are measured as body position changes. If you want to understand how those procedures work, our guide to dysautonomia testing explained walks through the standard workup.
Where does inflammation testing fit? Not as a diagnostic, but as one more source of objective information. For someone whose routine labs keep coming back normal, a broad proteomic panel measures many cytokines, chemokines, interferons, and their receptors from a single small blood sample and benchmarks each against a healthy reference. Because you can retest over time, you can see which signals shift and which stay steady. If you want to understand which specific markers a broad panel looks at, you can see what Muno Mirror measures. This is measurement and benchmarking for research and informational use, to review with your own doctor. It is not a diagnosis, and it is not a substitute for medical care.
Why does objective data matter when you feel dismissed?
Many people with dysautonomia describe years of being told their symptoms are anxiety, deconditioning, or nothing at all. That experience is real, and it is exhausting. Objective measurement will not by itself resolve a condition, but seeing numbers on a page, whether from a tilt-table study or from a wider look at immune signaling, can change the conversation with a clinician from your description alone to shared data. For the broader context on how ongoing immune activity relates to long-term symptoms, see our overview of chronic inflammation and chronic illness.
Frequently asked questions
Is dysautonomia an autoimmune or inflammatory disease?
Not by definition. Dysautonomia is a disorder of autonomic nervous system regulation. Some forms are linked to autoimmune or immune-mediated processes, and researchers are studying inflammation as a possible contributor, especially after infection. But dysautonomia as a whole is not classified as a single autoimmune or inflammatory disease.
What are the most common causes of dysautonomia?
Common recognized associations include onset after a viral infection, autoimmune conditions, connective tissue disorders such as hypermobility syndromes, and other diseases like diabetes. In many people no single cause is ever identified, which is part of what makes the condition so difficult to work up.
Can inflammation testing diagnose dysautonomia?
No. There is no validated inflammation blood test that diagnoses dysautonomia. Diagnosis is clinical and relies on autonomic testing such as an active stand or tilt-table study. Inflammation profiling can add context about immune activity to discuss with your doctor, but it does not diagnose the condition.
Why do my standard labs look normal if I have dysautonomia?
Routine bloodwork was not designed to measure autonomic function or the wider immune signaling network. A normal CBC, thyroid panel, or CRP does not rule out dysautonomia, because those tests look at different things. This is a common reason people feel unheard despite genuine symptoms.